This inventor holds 4 USPTO granted patents. Top assignee: Aeras Global Tb Vaccine Foundation. Active years: 2009-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2014
Title: Innovations of Ravi P Anantha: Advancements in Bacterial Delivery Systems
Introduction
Ravi P Anantha, an innovative inventor located in Gaithersburg, MD, has made significant contributions to the field of biotechnology. With a total of four patents to his name, Anantha is recognized for his pioneering work in enhancing transgene expression through bacterial-based delivery systems. His research focuses on overcoming the challenges associated with eukaryotic type I interferon responses, effectively improving the delivery of therapeutic genes.
Latest Patents
Anantha's most recent patents highlight his groundbreaking research. One of his notable innovations is a method designed to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response. This inventive approach provides recombinant bacterial delivery systems that not only deliver transgenes of interest to eukaryotic cells but also incorporate suppressors that mitigate the eukaryotic type I interferon response. By suppressing this response, Anantha enables improved expression of the encoded transgene, paving the way for more effective gene therapies.
Career Highlights
Ravi P Anantha is currently affiliated with the Aeras Global TB Vaccine Foundation. His work within this organization centers on developing innovative solutions to address infectious diseases, particularly tuberculosis. Anantha's contributions reflect a commitment to advancing biotechnology and improving global health outcomes through scientific research.
Collaborations
Throughout his career, Anantha has collaborated with esteemed colleagues, including Jerald C Sadoff and Mohamad Fakruddin Jamiluddin. These partnerships have undoubtedly enhanced the impact of his research, fostering an environment of shared knowledge and collective advancement in the field of biotechnology.
Conclusion
Ravi P Anantha stands as a prominent figure in the biotechnology landscape, with innovative patents that significantly enhance transgene expression in bacterial delivery systems. His work, coupled with collaborations at the Aeras Global TB Vaccine Foundation, contributes valuable insights and advancements towards more effective therapeutic approaches. Anantha's commitment to innovation continues to inspire new pathways in the research and development of genetic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile